131 Results for "

CPT

" in MedChemExpress (MCE) Product Catalog:
Products (131)

131 Results for "CPT" in MCE Product Catalog:

149
149 Publications Verification
Art. -Nr.: HY-50202
CAS. Nr.: 124083-20-1
Synonyms: (R)-(+)-Etomoxir
Etomoxir ((R)-(+)-Etomoxir) is an irreversible inhibitor of carnitine palmitoyltransferase 1a (CPT-1a), inhibits fatty acid oxidation (FAO) through CPT-1a and inhibits palmitate β-oxidation in human, rat and guinea pig.
loading...
    loading...
149
149 Publications Verification
Art. -Nr.: HY-50202A
CAS. Nr.: 828934-41-4
Synonyms: (R)-(+)-Etomoxir sodium salt
Etomoxir((R)-(+)-Etomoxir) sodium salt is an irreversible inhibitor of carnitine palmitoyltransferase 1a (CPT-1a), inhibits fatty acid oxidation (FAO) through CPT-1a and inhibits palmitate β-oxidation in human, rat and guinea pig .
loading...
    loading...
81
81 Cited Publications
Art. -Nr.: HY-16562
CAS. Nr.: 97682-44-5
Synonyms: (+)-Irinotecan; CPT-11; VAL-413free base
Target:  

Topoisomerase Autophagy

Forschungsgebiete:  

Neurological Disease Cancer

Irinotecan ((+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex .
loading...
    loading...
81
81 Cited Publications
Art. -Nr.: HY-16562A
CAS. Nr.: 100286-90-6
Synonyms: (+)-Irinotecan hydrochloride; CPT-11 hydrochloride; VAL-413
Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer .
loading...
    loading...
81
81 Cited Publications
Art. -Nr.: HY-16568
CAS. Nr.: 136572-09-3
Synonyms: (+)-Irinotecan hydrochloride trihydrate; CPT-11 hydrochloride trihydrate
Target:  

Topoisomerase Autophagy

Forschungsgebiete:  

Cancer

Irinotecan hydrochloride trihydrate ((+)-Irinotecan hydrochloride trihydrate) is a topoisomerase I inhibitor with antitumor activity .
loading...
    loading...
70
70 Cited Publications
Art. -Nr.: HY-16560
CAS. Nr.: 7689-03-4
Synonyms: Campathecin; (S)-(+)-Camptothecin; CPT
Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM . Camptothecin (CPT) exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers, modulates hypoxia-inducible factor-1α (HIF-1α) activity by changing microRNAs (miRNA) expression patterns in human cancer cells .
loading...
    loading...
62
62 Cited Publications
Art. -Nr.: HY-N0197
CAS. Nr.: 21967-41-9
Synonyms: Baicalein 7-O-β-D-glucuronide
Baicalin, as a flavonoid glycoside, is an allosteric carnitine palmityl transferase 1 (CPT1) activator. Baicalin reduces the expression of NF-κB .
loading...
    loading...
52
52 Cited Publications
Art. -Nr.: HY-12364
CAS. Nr.: 218137-86-1
Reinheit:  99.91%
C75 is a synthetic fatty-acid synthase (FASN) inhibitor; inhibits prostate cancer cells PC3 with an IC50 of 35 μM . C75 is a potent CPT1A activator .
loading...
    loading...
13
13 Cited Publications
Art. -Nr.: HY-108473
CAS. Nr.: 1279713-77-7
Reinheit:  99.34%
Synonyms: TLR3-IN-1
Forschungsgebiete:  

Cancer

CU-CPT 4a (TLR3-IN-1) is a potent, highly selective TLR3 signaling inhibitor. CU-CPT 4a represses the expression of downstream signaling pathways mediated by the TLR3/dsRNA complex, including TNF-α and IL-1β .
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-108471
CAS. Nr.: 1416324-85-0
Reinheit:  98.08%
Forschungsgebiete:  

Cancer

CU-CPT22 is a potent protein complex of toll-like receptor 1 and 2 (TLR1/2) inhibitor, and competes with the synthetic triacylated lipoprotein (Pam3CSK4) binding to TLR1/2 with a Ki of 0.41 µM. CU-CPT22 blocks Pam3CSK4-induced TLR1/2 activation with an IC50 of 0.58 µM .
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-B1334A
CAS. Nr.: 6724-53-4
Perhexiline maleate is an orally active CPT1 and CPT2 inhibitor that reduces fatty acid metabolism. Perhexiline maleate induces mitochondrial dysfunction and apoptosis in hepatic cells. Perhexiline maleate can cross the blood brain barrier (BBB) and shows anti-tumor activity. Perhexiline maleate can be used in the research of cancers, and cardiovascular disease like angina .
loading...
    loading...
7
7 Cited Publications
Art. -Nr.: HY-B1334
CAS. Nr.: 6621-47-2
Perhexiline is an orally active CPT1 and CPT2 inhibitor that reduces fatty acid metabolism. Perhexiline induces mitochondrial dysfunction and apoptosis in hepatic cells. Perhexiline can cross the blood brain barrier (BBB) and shows anti-tumor activity. Perhexiline can be used in the research of cancers, and cardiovascular disease like angina .
loading...
    loading...
5
5 Cited Publications
Art. -Nr.: HY-112667
CAS. Nr.: 2165340-32-7
Reinheit:  99.74%
Forschungsgebiete:  

Inflammation/Immunology

CU-CPT-9a is a specific TLR8 antagonist, with an IC50 of 0.5 nM.
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-N2593
CAS. Nr.: 32507-66-7
Isorhapontigenin is an orally active dietary polyphenol. Isorhapontigenin acts as a potent antioxidant that reduces the production of reactive oxygen species (ROS). Isorhapontigenin promotes the binding of JUN to the AP-1 site on the SESN2 promoter, induces SESN2 transcription, triggers MAPK8-dependent JUN activation, and upregulates the expression of PPAR-α, PGC-1α and CPT-1A to facilitate fatty acid oxidation. Isorhapontigenin induces autophagy, apoptosis and preadipocyte differentiation; it inhibits tumor growth, cell invasion, NF-κB transcriptional activity, the PI3K/Akt signaling pathway, STAT1 phosphorylation and MMP-2 expression. Isorhapontigenin alleviates oxidative stress, inflammatory cytokine release and triglyceride accumulation; it increases intracellular ATP levels and promotes Nrf2 nuclear translocation. Isorhapontigenin improves insulin sensitivity in adipose tissue and glucose tolerance, and reduces postprandial blood glucose, insulin and free fatty acid levels. Isorhapontigenin is applicable to research on bladder cancer, liver injury, chronic obstructive pulmonary disease, acute lung injury and type 2 diabetes .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-101929
CAS. Nr.: 2109805-75-4
Reinheit:  99.00%
Forschungsgebiete:  

Inflammation/Immunology Cancer

CU-CPT17e is a potent multi-Toll-like receptor (TLR) agonist that activates TLR3, TLR8, and TLR9.
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-16482
CAS. Nr.: 250694-07-6
Teglicar is a selective and reversible orally active liver isoform of carnitine palmitoyl-transferase 1 (L-CPT1) inhibitor with an IC50 value of 0.68 μM and a Ki value of 0.36 μM. Teglicar has a potential antihyperglycemic propert. Teglicar can be used for the research of diabetes and neurodegenerative disease including Huntington's disease (HD) .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-136408
CAS. Nr.: 108347-84-8
Reinheit:  ≥98.0%
Synonyms: Malonyl coenzyme A lithium
Malonyl CoA (Malonyl Coenzyme A) lithium is an inhibitor of carnitine palmitoyl transferase 1 (CPT1). High Malonyl CoA lithium concentrations suppress fatty acid oxidation, while low Malonyl CoA lithium concentrations are permissive for fat oxidation .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-112050
CAS. Nr.: 125079-83-6
Reinheit:  99.98%
Synonyms: TLR8-specific antagonist
Forschungsgebiete:  

Inflammation/Immunology

CU-CPT-8m is a specific TLR8 antagonist, with an IC50 of 67 nM.
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-50670
CAS. Nr.: 942999-61-3
DGAT-1 inhibitor 2 is an orally active DGAT-1 inhibitor with IC50 values of 15 nM and 9 nM for human DGAT-1 and rat DGAT-1, respectively. DGAT-1 inhibitor 2 increases ROS concentration, GRP78, and PERK protein abundance. DGAT-1 inhibitor 2 increases SREBF1, CPT1A, and MTTP mRNA in fatty acid-treated cells. DGAT-1 inhibitor 2 improves obesity .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-107543
CAS. Nr.: 634207-53-7
Reinheit:  99.81%
Synonyms: 8-CPT-2'-O-Me-cAMP sodium
Target:  

Ras

Forschungsgebiete:  

Cardiovascular Disease

8-pCPT-2′-O-Me-cAMP (8-CPT-2'-O-Me-cAMP) sodium, an analog of cAMP, is an activator of exchange proteins activated by cAMP (Epac). 8-pCPT-2′-O-Me-cAMP sodium activates Epac1 (EC50 = 2.2 μM), but not PKA (EC50 >10 μM). 8-pCPT-2′-O-Me-cAMP sodium stimulates Epac-mediated Ca 2+ release in pancreatic β-cells in vitro. 8-pCPT-2′-O-Me-cAMP sodium is a Rap1 activator. 8-pCPT-2′-O-Me-cAMP sodium enhances the retinal pigment epithelium barrier against the pathological choroidal endothelial cell invasion that occurs in macular degeneration .
loading...
    loading...